Efficacy of epidural analgesia in patients with cancer pain: A retrospective observational study

Yonsei Medical Journal

Volumn 53, Issue 3, 2012, Pages 649-653

  Jeon, Yeon Soo ^a   Lee, Jung Ah ^a   Choi, Jin Woo ^a   Kang, Eu Gene ^a   Jung, Hong Soo ^a   Kim, Hoon Kyo ^a   Shim, Byoung Yong ^a   Park, Jae Hee ^a   Joo, Jin Deok ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Bupivacaine; Cancer pain; Epidural analgesia; Morphine over

Indexed keywords

BUPIVACAINE; KETAMINE; MORPHINE;

ADULT; CANCER PAIN; CATHETERIZATION; EPIDURAL ANESTHESIA; EPIDURAL CATHETER; EPIDURAL CATHETERIZATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PAIN THRESHOLD; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION;

ADULT; ANALGESIA, EPIDURAL; BUPIVACAINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; RETROSPECTIVE STUDIES;

EID: 84859747120     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.3.649     Document Type: Review

References (23)

1. Ministry of Health and Welfare, Department of Central Cancer Registry, 2006-2007 cancer statistics 2009. p.1-34.
2. Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB. The epidemiology of cancer pain. Cancer Invest 2005;23:182-90.
3. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001;93:247-57.
4. Benedetti C, Brock C, Cleeland C, Coyle N, Dubé JE, Ferrell B, et al. NCCN Practice Guidelines for Cancer Pain. Oncology (Williston Park) 2000;14:135-50.
5. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65-76.
6. Samuelsson H, Malmberg F, Eriksson M, Hedner T. Outcomes of epidural morphine treatment in cancer pain: nine years of clinical experience. J Pain Symptom Manage 1995;10:105-12.
7. Smitt PS, Tsafka A, Teng-van de Zande F, van der Holt R, Elswijk-de Vries I, Elfrink E, et al. Outcome and complications of epidural analgesia in patients with chronic cancer pain. Cancer 1998;83:2015-22.
8. Samuelsson H, Hedner T. Pain characterization in cancer patients and the analgetic response to epidural morphine. Pain 1991;46:3-8.
9. Du Pen SL, Kharasch ED, Williams A, Peterson DG, Sloan DC, Hasche-Klunder H, et al. Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain 1992;49:293-300.
10. Ballantyne JC, Carwood CM. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Cochrane Database Syst Rev 2005:CD005178.
11. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 1991;6: 368-73.
12. Erdine S, Aldemir T. Long-term results of peridural morphine in 225 patients. Pain 1991;45:155-9.
13. Burton AW, Rajagopal A, Shah HN, Mendoza T, Cleeland C, Hassenbusch SJ 3rd, et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med 2004;5:239-47.
14. Mercadante S. Controversies over spinal treatment in advanced cancer patients. Support Care Cancer 1998;6:495-502.
15. Jeon YS, Kim HK, Cleeland CS, Wang XS. Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer 2007;15:463-9.
16. Hong SH, Roh SY, Kim SY, Shin SW, Kim CS, Choi JH, et al. Change in cancer pain management in Korea between 2001 and 2006: results of two nationwide surveys. J Pain Symptom Manage 2011;41:93-103.
17. Sjöberg M, Karlsson PA, Nordborg C, Wallgren A, Nitescu P, Appelgren L, et al. Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. Anesthesiology 1992;76:173-86.
18. Congedo E, Sgreccia M, De Cosmo G. New drugs for epidural analgesia. Curr Drug Targets 2009;10:696-706.
19. Ruppen W, Derry S, McQuay HJ, Moore RA. Infection rates associated with epidural indwelling catheters for seven days or longer: systematic review and meta-analysis. BMC Palliat Care 2007; 6:3.
20. Hogan Q, Haddox JD, Abram S, Weissman D, Taylor ML, Janjan N. Epidural opiates and local anesthetics for the management of cancer pain. Pain 1991;46:271-9.
21. Hogan QH. Loculated? Encapsulated? Indented? Pain 1993;53: 241-2.
22. Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, et al. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. J Pain Symptom Manage 2009; 38:683-90.
23. Mercadante S, Agnello A, Armata MG, Pumo S. The inappropriate use of the epidural route in cancer pain. J Pain Symptom Manage 1997;13:233-7.